Medication adherence and clinical outcomes among Libyan patients with chronic diseases: A comparative study of public and private healthcare sectors
Nasruddin E. Elreyani, Amira I. Frewan, Aya M. Abushawashi
Abstract
Medication non-adherence remains a major barrier to optimal management of chronic diseases worldwide, leading to increased morbidity, hospitalizations, and healthcare costs. In Libya, data on adherence and its determinants are limited, particularly when comparing the public and private healthcare sectors. This descriptive cross-sectional study assessed medication adherence among 400 adult Libyan patients with chronic conditions attending a public outpatient clinic at Tripoli Medical Center and a private clinic, Al-Mustaqbel Al-Mushreq, over a three-month period. A structured Patient Compliance Questionnaire (PCQ) was administered to evaluate adherence behaviors, clinical outcomes, and patient perceptions. Chi-square tests, t-tests, and logistic regression analyses were applied to identify factors associated with adherence. The mean age of participants was 57.4±0.9 years, with balanced gender distribution. Significant differences were observed between sectors: patients in the private sector reported higher adherence to medication and monitoring schedules (P<0.05), greater perceived improvement since diagnosis (P<0.01), and fewer concomitant diseases (P<0.05). Logistic regression identified older age (OR 1.05, 95.0% CI 1.02-1.08), longer duration of medication use (OR 1.07, 95.0% CI 1.01-1.14), and unemployment or retirement status (OR 1.54, 95.0% CI 1.10-2.17) as positive predictors of adherence, whereas poor self-perceived health status was associated with lower adherence (OR 0.68, 95.0% CI 0.49-0.94). These findings highlight the influence of socio-demographic and clinical factors on medication-taking behaviors and underscore the importance of targeted interventions. Integration of clinical pharmacy services, including patient education, counseling, and follow-up, may improve adherence and health outcomes in Libyan chronic disease populations. Strengthening public sector resources and implementing adherence-focused strategies are essential to reducing disparities and enhancing overall care quality.
Keywords
References
- Bredan A, Bakoush O. COVID-19 epidemic in Libya. Libyan Journal of Medicine. 2021; 16(1): 1871798. doi: 10.1080/19932820.2021.1871798
- Marcum ZA, Jiang S, Bacci JL, Ruppar TM. Pharmacist-led interventions to improve medication adherence in older adults: A meta-analysis. Journal of the American Geriatrics Society. 2021; 69(11): 3301-3311. doi: 10.1111/jgs.173
- Bott AM, Collins J, Daniels-Costa S, Maves K, Runkle A, Simon A, et al. Clinical pharmacists improve patient outcomes and expand access to care. Federal Practitioner. 2019; 36(10): 471-475. PMCID: PMC6837332.
- Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clinic Proceedings. 2011; 86(4): 304-314. doi: 10.4065/mcp.2010.0575
- Farhana L, Rahayu FP, Sholihah S, Sweileh W, Abdulah R, Alfian SD. Effectiveness of pharmacist-led intervention on medication adherence in chronic diseases: A systematic review of randomized controlled trials. Patient Prefer Adherence. 2025; 19: 2161-2178. doi: 10.2147/PPA.S530503
- Presley B, Groot W, Pavlova M. Pharmacy-led interventions to improve medication adherence among adults with diabetes: A systematic review and meta-analysis. Research in Social and Administrative Pharmacy. 2019; 15(9): 1057-1067. doi: 10.1016/j.sapharm.2018.09.021
- Sabaté E (2003) Adherence to long-term therapies: evidence for action. World Health Organization. Available from: https://www.who.int/chp/knowledge/publications/adherence_report/en/
- Osterberg L, Blaschke T. Adherence to medication. The New England Journal of Medicine. 2005; 353(5): 487-497. doi: 10.1056/NEJMra050100
- Demonceau J, Ruppar TM, Kristanto P, Hughes KD, Fargher E, Kardas P, et al. Identification and assessment of adherence-enhancing interventions: a systematic review and meta-analysis. Drugs. 2013; 73(6): 545-562. doi: 10.1007/s40265-013-0031
- van Sluisveld N, Zegers M, Natsch S, Wollersheim H. Medication reconciliation at hospital admission and discharge: insufficient knowledge, unclear task reallocation and lack of collaboration as major barriers to medication safety. BMC Health Services Research. 2012; 12: 170. doi: 10.1186/1472-6963-12-170
- Fernandes BD, Ribeiro LC, dos Santos JCP, Ayres LR, Chemello C. Medication reconciliation at hospital admission and discharge: Evaluation of fidelity and process outcomes in a real-world setting. International Journal of Clinical Practice. 2021; 75(10): e14656. doi: 10.1111/ijcp.14656
- Osamor PE, Owumi BE. Factors associated with treatment compliance in hypertension in Nigeria. International Journal of General Medicine. 2011; 4: 75-81. doi: 10.2147/IJGM.S15665
- Horne R, Chapman SCE, Freemantle N, Forbes A, Cooper V. Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: A meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013; 8(12): e80633. doi: 10.1371/journal.pone.0080633
- Gadkari AS, McHorney CA. Unintentional non-adherence to chronic prescription medications: how unintentional is it really? BMC Health Services Research. 2012; 12: 98. doi: 10.1186/1472-6963-12-98
- World Health Organization (2014) Global status report on noncommunicable diseases 2014. Geneva: WHO. Available from: https://www.who.int/nmh/publications/ncd-status-report-2014/en/
- Jin J, Sklar GE, Min Sen Oh V, Chuen Li S. Factors affecting therapeutic compliance: A review from the patient’s perspective. Therapeutics and Clinical Risk Management. 2008; 4(1): 269-286. doi: 10.2147/tcrm.s1458
- Hovstadius B, Petersson G. Factors influencing drug adherence among the elderly with chronic diseases. Journal of Clinical Pharmacy and Therapeutics. 2011; 36(6): 600-606. doi: 10.1111/j.1365-2710.2010.01199.x
- Fenta ET, Ayal BG, Kidie AA, Anagaw TF, Mekonnen TS, Ketema Bogale E, et al. Barriers to medication adherence among patients with non-communicable disease in North Wollo Zone Public Hospitals: Socio-ecologic perspective, 2023. Patient Prefer Adherence. 2024; 18: 733-744. doi: 10.2147/PPA.S452196
- Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Frontiers in Pharmacology. 2013; 4: 91. doi: 10.3389/fphar.2013.00091
- DiMatteo MR (2004) Variations in patients’ adherence to medical recommendations: A quantitative review of 50 years of research. Medical Care. 2004; 42(3): 200-209. doi: 10.1097/01.mlr.0000114908.90348.f9
- DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine. 2000; 160(14): 2101-2107. doi: 10.1001/archinte.160.14.2101
- Elfituri AA, Sherif FM. Novel clinical pharmacy practice: Extended role and improved competencies. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2022; 2(1): 1-3. doi: 10.5281/zenodo.6397651
- Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clinic Proceedings. 2011; 86(4): 304-314. doi: 10.4065/mcp.2010.0575
- Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews. 2014; 11: CD000011. doi: 10.1002/14651858.C
- Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: A key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Current Opinion in Cardiology. 2004; 19(4): 357-362. doi: 10.1097/01.hco. 0000139860.81103.7e
- DiMatteo MR. Social support and patient adherence to medical treatment: A meta-analysis. Health Psychology. 2004; 23(2): 207-218. doi: 10.1037/0278-6133.23.2.207
- Alhomri ASH, Battah AA, Elberry AA, Abdelall EKA, Hussein R. The role of clinical pharmacist in monitoring drug therapy in the cardiovascular and coronary care units in Libya. Pharmacy Practice. 2024; 22(4): 1-13. doi: Nil.
- Al-Arkee S, Al-ani OA. Community pharmacist-led interventions to improve medication adherence in patients with cardiovascular disease: A systematic review of randomized controlled trials. International Journal of Pharmacy Practice. 2023; 3(3): 269-275. doi: 10.1093/ijpp/riad013
- Alssageer MA, Khattab BF, Bakouri AH. Physicians' attitudes, expectations, and experiences about clinical pharmacists and the barriers they have in developing a collaborative relationship with them. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2024; 4(3): 27-38. doi. 10.5281/zenodo.13324209
- Fetensa G, Yadecha B, Tolossa T, Bekuma TT. Medication adherence and associated factors among chronic heart failure clients on follow-up Oromia Region, West Ethiopia. Cardiovascular and Hematological Agents in Medicinal Chemistry. 2019; 17(2): 104-114. doi: 10.2174/1871525717666191019162254
- Alshami HA, Hussein MSE, Alshwehdi A, Benhalim E, Bukar S, Hussin HF, et al. Beyond self-assessment: Understanding Libyan pharmacists' confidence and barriers to conducting pharmacy practice research. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2024; 4(4): 58-67. doi. 10.5281/zenodo. 14279010
- Legesse TA, Reta MA. Adherence to antiretroviral therapy and associated factors among people living with HIV/AIDS in Hara Town and its surroundings, North-Eastern Ethiopia: A cross-sectional study. Ethiopian Journal of Health Science. 2019; 29(3): 299-308. doi: 10.4314/ejhs.v29i3.2
- Aldaajani MZ, Almutairi AM, Almuteriee EH, Almorshed AS, Alrbian AS, Alwalie MS, et al. The role of clinical pharmacists in chronic disease management: Review. International Journal of Health Sciences. 2024; 8(S1): 1766-1776. doi: 10.53730/ijhs.v8nS1.15389
- Sapkota B, Pandey B, Sapkota B, Dhakal K, Aryal B. A systematic review and meta-analysis on pharmacist-led interventions for the management of peptic ulcer disease. PLoS ONE. 2025; 20(3): e0320181. doi. 10.1371/journal.
- Choudhry NK, Avorn J, Glynn RJ, Antman EM, Schneeweiss S, Toscano M, Reisman L, et al. Full coverage for preventive medications after myocardial infarction. The New England Journal of Medicine. 2011; 365(22): 2288-2097. doi: 10.1056/NEJMsa1107913
- Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Annals of Internal Medicine. 2012; 157(11): 785-795. doi: 10.7326/0003-4819-157-11-201212040-00538
- Thakkar J, Kurup R, Laba TL, Santo K, Thiagalingam A, Rodgers A, Woodward M, Redfern J, Chow CK. Mobile telephone text messaging for medication adherence in chronic disease: A meta-analysis. Telemedicine and e-Health. 2016; 22(5): 403-411. doi: 10.1089/tmj.2015.0206
- Blood AJ, Saag H, Chesler A, Ameripour D, Gutierrez M, Nguyen V, et al. Integrating ambulatory care pharmacists into value-based primary care: A scalable solution to chronic disease. Journal of Primary Care and Community Health. 2025; 16: 21501319241312041. doi: 10.1177/21501319241312041
- Tsige AW, Kotiso TA, Ayenew KD, Ayele SG. Pharmacist intervention to improve adherence to medication among heart failure patients at North East Ethiopia hospital. Pharmacology Research and Perspectives. 2024; 12(3): e1199. doi: 10.1002/prp2.1199
- Religioni U, Barrios-Rodríguez R, Requena P, Borowska M, Ostrowski J. Enhancing therapy adherence: Impact on clinical outcomes, healthcare costs, and patient quality of life. Medicina (Kaunas). 2025; 61(1): 153. doi: 10.3390/ medicina61010153
- Rendrayani F, Utami AM, Insani WN, Puspita F, Alfian SD, Nguyen T, Puspitasari IM. Interventions to improve pharmacists’ competency in chronic disease management: a systematic review of randomized controlled trials. BMC Medical Education. 2024; 24: 144. doi: 10.1186/s12909-024-06393-z
- Paul SK. Assessment of knowledge and attitude of adverse drug reactions among healthcare professionals in Bangladesh. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2025; 5(2): 70-78. doi: 10.5281/ zenodo.15275065
- Taghizadeh P. The role of pharmacists in managing conditions like hypertension: The case of Northern Cyprus. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2025; 5(3): 28-37. doi: 10.5281/zenodo. 15921080
- MacEwan JP, Silverstein AR, Shafrin J, Lakdawalla DN, Hatch A, Forma FM. Medication adherence patterns among patients with multiple serious mental and physical illnesses. Advances in Therapy. 2018; 35(5): 671-685. doi: 10.1007/s12325-018-0700-6
- Sallom H, Abdi A, Halboup AM, Başgut B. Evaluation of pharmaceutical care services in the Middle East Countries: A review of studies of 2013-2020. BMC Public Health. 2023; 23(1): 1364. doi: 10.1186/s12889-023-91
Submitted date:
08/08/2025
Reviewed date:
09/10/2025
Accepted date:
09/13/2025